Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias Curr Neurol Neurosci Rep (2017) 17: 73 DOI 10.1007/s11910-017-0789-z NEUROIMAGING (N PAVESE, SECTION EDITOR) Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias 1 1,2 1,3 Nicolaas I. Bohnen & Martijn L. T. M. Müller & Kirk A. Frey Published online: 14 August 2017 Springer Science+Business Media, LLC 2017 Abstract Alzheimer disease (AD; highest). However, tau binding in Purpose of Review The aims of the study were to review DLB, including the medial temporal lobe, is substantially low- recent advances in molecular imaging in the Lewy body de- er than in AD. mentias (LBD) and determine if these may support the clinical Summary Alzheimer-type proteinopathies appear to be more but contested temporal profile distinction between Parkinson common in DLB compared to PDD with relative but no ab- disease (PD) with dementia (PDD) versus dementia with solute differences. Given the spectrum of overlapping pathol- Lewy bodies (DLB). ogies, future α-synuclein ligands are expected to have the best Recent Findings There do not appear to be major regional potential to distinguish the LBD from pure AD. cerebral metabolic or neurotransmitter distinctions between . . PDD and DLB. However, recent studies highlight the relative Keywords Acetylcholine β-Amyloid DementiawithLewy . . . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Neurology and Neuroscience Reports Springer Journals

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias

Loading next page...
 
/lp/springer_journal/molecular-imaging-and-updated-diagnostic-criteria-in-lewy-body-z2VGt0AJYs
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Neurology; Neurosciences
ISSN
1528-4042
eISSN
1534-6293
D.O.I.
10.1007/s11910-017-0789-z
Publisher site
See Article on Publisher Site

Abstract

Curr Neurol Neurosci Rep (2017) 17: 73 DOI 10.1007/s11910-017-0789-z NEUROIMAGING (N PAVESE, SECTION EDITOR) Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias 1 1,2 1,3 Nicolaas I. Bohnen & Martijn L. T. M. Müller & Kirk A. Frey Published online: 14 August 2017 Springer Science+Business Media, LLC 2017 Abstract Alzheimer disease (AD; highest). However, tau binding in Purpose of Review The aims of the study were to review DLB, including the medial temporal lobe, is substantially low- recent advances in molecular imaging in the Lewy body de- er than in AD. mentias (LBD) and determine if these may support the clinical Summary Alzheimer-type proteinopathies appear to be more but contested temporal profile distinction between Parkinson common in DLB compared to PDD with relative but no ab- disease (PD) with dementia (PDD) versus dementia with solute differences. Given the spectrum of overlapping pathol- Lewy bodies (DLB). ogies, future α-synuclein ligands are expected to have the best Recent Findings There do not appear to be major regional potential to distinguish the LBD from pure AD. cerebral metabolic or neurotransmitter distinctions between . . PDD and DLB. However, recent studies highlight the relative Keywords Acetylcholine β-Amyloid DementiawithLewy . . .

Journal

Current Neurology and Neuroscience ReportsSpringer Journals

Published: Aug 14, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off